HealthEquity (HQY) Hits New 12-Month High and Low at $72.44

HealthEquity (NASDAQ:HQY) hit a new 52-week high and low during trading on Thursday . The stock traded as low as $72.44 and last traded at $72.24, with a volume of 388256 shares traded. The stock had previously closed at $71.69.

Several brokerages have commented on HQY. Robert W. Baird boosted their target price on shares of HealthEquity from $48.00 to $49.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 7th. Cantor Fitzgerald restated a “buy” rating and set a $60.00 target price on shares of HealthEquity in a research report on Thursday, February 22nd. Chardan Capital boosted their target price on shares of HealthEquity from $62.00 to $77.00 and gave the stock a “buy” rating in a research report on Tuesday, March 20th. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $57.00 target price on the stock in a research report on Saturday, February 10th. Finally, BidaskClub upgraded shares of HealthEquity from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 2nd. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. HealthEquity presently has an average rating of “Buy” and an average target price of $68.30.

The stock has a market capitalization of $4.34 billion, a P/E ratio of 133.78, a PEG ratio of 2.85 and a beta of 1.39.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Monday, March 19th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. HealthEquity had a net margin of 20.64% and a return on equity of 13.47%. The business had revenue of $60.44 million for the quarter, compared to analyst estimates of $58.46 million. equities analysts forecast that HealthEquity will post 0.77 earnings per share for the current fiscal year.

In related news, insider Stephen Neeleman sold 240,654 shares of the business’s stock in a transaction dated Thursday, May 10th. The shares were sold at an average price of $69.95, for a total value of $16,833,747.30. Following the completion of the transaction, the insider now owns 654 shares of the company’s stock, valued at approximately $45,747.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jon Kessler sold 20,442 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.02, for a total transaction of $1,124,718.84. Following the completion of the transaction, the insider now directly owns 446,332 shares of the company’s stock, valued at approximately $24,557,186.64. The disclosure for this sale can be found here. Insiders sold a total of 631,342 shares of company stock worth $41,886,672 over the last quarter. Insiders own 29.00% of the company’s stock.

A number of hedge funds have recently made changes to their positions in HQY. Carillon Tower Advisers Inc. acquired a new position in HealthEquity in the 4th quarter valued at about $34,100,000. Victory Capital Management Inc. raised its stake in HealthEquity by 116.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock valued at $48,139,000 after purchasing an additional 555,027 shares during the last quarter. Eagle Asset Management Inc. raised its stake in HealthEquity by 58.6% in the 4th quarter. Eagle Asset Management Inc. now owns 1,136,645 shares of the company’s stock valued at $53,206,000 after purchasing an additional 419,914 shares during the last quarter. Champlain Investment Partners LLC acquired a new position in HealthEquity in the 1st quarter valued at about $25,208,000. Finally, BlackRock Inc. raised its stake in HealthEquity by 3.8% in the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock valued at $315,026,000 after purchasing an additional 244,819 shares during the last quarter. 98.16% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit